首页> 外文OA文献 >Plasmodium falciparum in vitro continuous culture conditions: A comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle
【2h】

Plasmodium falciparum in vitro continuous culture conditions: A comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle

机译:体外连续培养条件下的恶性疟原虫:在整个无性红细胞生命周期中寄生虫敏感性和对抗疟疾药物的耐受性比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The continuous culture of Plasmodium falciparum is often seen as a means to an end, that end being to probe the biology of the parasite in question, and ultimately for many in the malaria drug discovery arena, to identify means of killing the parasite in order to treat malaria. In vitro continuous culture of Plasmodium falciparum is a fundamental requirement when undertaking malaria research where the primary objectives utilise viable parasites of a desired lifecycle stage. This investigation, and resulting data, compared the impact culturing Plasmodium falciparum long term (4 months) in different environmental conditions had on experimental outcomes and thus conclusions. The example presented here focused specifically on the effect culture conditions had on the in vitro tolerance of Plasmodium falciparum to standard anti-malarial drugs, including artemisinin and lumefantrine. Historical data from an independent experiment for 3D7-ALB (5% O2) was also compared with that obtained from this study. We concluded that parasites cultured for several months in media supplemented with a serum substitute such as Albumax II® or within hyperoxic conditions (21% O2), demonstrate highly variable responses to artemisinin and lumefantrine but not all anti-malarial drugs, when compared to those cultured in human serum in combination with Albumax II® under normoxic conditions (5% O2) for the parasite.
机译:恶性疟原虫的连续培养通常被认为是达到目的的一种手段,该目的是探究有关寄生虫的生物学,并最终在疟疾药物发现领域中,对于许多人而言,以鉴定杀死该寄生虫的手段以治疗疟疾。进行疟疾研究时,恶性疟原虫的体外连续培养是一项基本要求,在该研究中,主要目标是利用所需生命周期阶段的活寄生虫。这项研究和所得数据比较了在不同环境条件下长期(4个月)培养恶性疟原虫对实验结果和结论的影响。此处提供的示例专门针对培养条件对恶性疟原虫对标准抗疟药(包括青蒿素和lumantantrine)的体外耐受性的影响。还比较了独立实验中3D7-ALB(5%O2)的历史数据与本研究获得的历史数据。我们得出的结论是,在添加了血清替代品(如AlbumaxII®)或高氧条件下(21%O2)的培养基中培养了几个月的寄生虫,与那些相比,对青蒿素和lumefantrine表现出高度可变的反应,但并不是所有抗疟药在常氧条件下(5%O2)与人白蛋白结合在人血清中培养寄生虫。

著录项

  • 作者

    Duffy Sandra; Avery Vicky;

  • 作者单位
  • 年度 2017
  • 总页数
  • 原文格式 PDF
  • 正文语种 English
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号